Nu Skin Enterprises Inc (NUS) Stock Forecast & Price Target
Nu Skin Enterprises Inc · NYSE
$4.75-0.09 (-1.86%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for NUS yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $4.75 current
Highest Target—
Average Target—
Lowest Target—
NUS analyst recommendation trends
86420
Sep
Oct
Nov
Strong BuyBuyHoldSellStrong Sell
RATING
SEP
OCT
NOV
Strong Buy
0
0
0
Buy
0
0
0
Hold
2
1
1
Sell
0
0
0
Strong Sell
0
0
0
Total
2
1
1
As of Nov, 0 of 1 firms rate NUS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NUS EPS & revenue forecast
EPS · NEXT QUARTER
$0.35
Range $0.35 – $0.35 · 1 analysts · +21% YoY
Next period, 1 analysts expect Nu Skin Enterprises Inc to earn $0.35 a share (range $0.35 – $0.35), versus $0.29 a year earlier. Full-year consensus is $0.82, growing to $1.16 the year after.
REVENUE · NEXT QUARTER
$384.0M
Range $384.0M – $384.0M · 1 analysts · +4% YoY
Revenue is expected to reach $384.0M (range $384.0M – $384.0M), +3.7% year-over-year. Full-year consensus is $1.3B, rising to $1.5B next year.
Top analysts covering Nu Skin Enterprises Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NUS.
#1
Linda Bolton Weiser
DA Davidson · Rank #393
Hold
$7.00+47.4% to target
Overall win rate
29%
+ Follow
#2
CB
Chasen Bender
Citigroup
Hold
$6.75+42.1% to target
Coverage
—
+ Follow
NUS stock forecast FAQ
Who is the most accurate analyst covering NUS?+
Among analysts who currently cover NUS, Linda Bolton Weiser of DA Davidson has the strongest overall Quantellect track record (Rank #393). Their current call is Hold with a $7.00 target.
What is Nu Skin Enterprises Inc's projected EPS for next quarter?+
The consensus estimate is $0.35 per share (range $0.35 – $0.35) across 1 analysts. Full-year EPS is projected at $0.82, rising to $1.16 the following year.
How much revenue is Nu Skin Enterprises Inc expected to report next quarter?+
Consensus revenue is $384.0M (range $384.0M – $384.0M). Full-year revenue is projected at $1.3B, growing to $1.5B next year.
Have analysts been upgrading or downgrading NUS lately?+
As of Nov, 0 of 1 firms rate NUS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NUS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
